These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22609351)

  • 1. Defeating Leishmania resistance to miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy.
    Luque-Ortega JR; de la Torre BG; Hornillos V; Bart JM; Rueda C; Navarro M; Amat-Guerri F; Acuña AU; Andreu D; Rivas L
    J Control Release; 2012 Aug; 161(3):835-42. PubMed ID: 22609351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug.
    de la Torre BG; Hornillos V; Luque-Ortega JR; Abengózar MA; Amat-Guerri F; Acuña AU; Rivas L; Andreu D
    Amino Acids; 2014 Apr; 46(4):1047-58. PubMed ID: 24445871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
    Papagiannaros A; Bories C; Demetzos C; Loiseau PM
    Biomed Pharmacother; 2005 Dec; 59(10):545-50. PubMed ID: 16325367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
    Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.
    Luque-Ortega JR; Rivas L
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1327-32. PubMed ID: 17283192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
    Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
    Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
    J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.
    Pérez-Victoria FJ; Castanys S; Gamarro F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2397-403. PubMed ID: 12878496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
    Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
    Mishra J; Singh S
    Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
    Paris C; Loiseau PM; Bories C; Bréard J
    Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
    Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
    Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
    Tripathi P; Jaiswal AK; Dube A; Mishra PR
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
    Verma NK; Singh G; Dey CS
    Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
    Sane SA; Shakya N; Haq W; Gupta S
    J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
    Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.